Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tardive Dystonia.

Frank Skidmore1, Stephen G Reich

  • 1University of Maryland School of Medicine, Department of Neurology, Suite N4W46, 22 South Greene Street, Baltimore, MD 21201, USA. sreich@som.umaryland.edu.

Current Treatment Options in Neurology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Segmental and Multifocal Isolated Dystonias: Similarities and Differences.

Movement disorders clinical practice·2025
Same author

Applying Wearable Sensors and Machine Learning to the Diagnostic Challenge of Distinguishing Parkinson's Disease from Other Forms of Parkinsonism.

Biomedicines·2025
Same author

Tremor in cervical dystonia.

Dystonia (Lausanne, Switzerland)·2024
Same author

Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies.

Movement disorders : official journal of the Movement Disorder Society·2024
Same author

Longitudinal predictors of health-related quality of life in isolated dystonia.

Journal of neurology·2023
Same author

Spirituality in Parkinson's Disease within a Sample from the USA.

Journal of religion and health·2023
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Tardive syndromes, including tardive dyskinesia, dystonia, and akathisia, are movement disorders caused by dopamine receptor blockers. Early detection and tailored management are crucial for patient comfort and function.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Tardive syndromes are movement disorders linked to dopamine receptor blocking agents.
  • These syndromes are phenomenologically distinct and require tailored treatments.
  • Patients can present with multiple tardive syndromes concurrently.

Purpose of the Study:

  • To review and discuss tardive syndromes, focusing on tardive dystonia treatment options.
  • To highlight the importance of early detection and management of tardive syndromes.
  • To inform clinicians about agents with lower risks of causing tardive syndromes.

Main Methods:

  • Literature review of tardive syndromes and their management.
  • Analysis of clinical presentation and treatment strategies for tardive dystonia.
  • Discussion of dopamine receptor blocking agents and their association with tardive syndromes.

Related Experiment Videos

Main Results:

  • Tardive syndromes encompass tardive dyskinesia, tardive dystonia, and tardive akathisia, among others.
  • These syndromes can manifest rapidly and may be permanent.
  • Management involves reviewing the primary diagnosis, characterizing the movement disorder, and adjusting medication.

Conclusions:

  • Prompt recognition and management of tardive syndromes are essential.
  • Treatment plans should be based on specific syndrome phenomenology to maximize patient function.
  • Clinicians should be aware of medications with lower risks, such as clozapine, quetiapine, and olanzapine.